|
1
|
729-9236-1791
|
DO 25-2856 DECLARACION(1-1) PROTOCOLO AR-DEX-22-04, NOS ACOGEMOS AL ACUERDO DE PROMOCION COMERCIAL ENTRE COLOMBIA Y EST
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
YOURWAY TRANSPORT BIOPHARMA SERVICES
|
2025-08-29
|
UNITED STATES
|
0.72 Kgs
|
0.72 KG
|
|
2
|
XXX-03063544
|
DO 25-2958 DECLARACION(3-3) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO.VINVIMA-25-0113697 DE FECHA 2025-08
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-27
|
CHINA
|
0.55 Kgs
|
25 U
|
|
3
|
XXX-03063544
|
DO 25-2958 DECLARACION(1-3) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-25-0113697 DE FECHA 2025-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-27
|
UNITED STATES
|
2 Kgs
|
28 U
|
|
4
|
XXX-03063544
|
DO 25-2958 DECLARACION(2-3) PROTOCOLO AR-DEX-22-01. (EXHALE-2).NO REEMBOLSABLE POR TRATARSE DE IMPORTACIONES PARA ESTUD
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-27
|
UNITED STATES
|
0.21 Kgs
|
0.21 KG
|
|
5
|
XXX-03063506
|
DO 25-2643 DECLARACION(2-4) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-24-0100109 DE FECHA 2024-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-05
|
UNITED STATES
|
65 Kgs
|
50 U
|
|
6
|
XXX-03063506
|
DO 25-2643 DECLARACION(1-4) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-24-0100109 DE FECHA 2024-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-05
|
UNITED STATES
|
6 Kgs
|
26 U
|
|
7
|
XXX-03063506
|
DO 25-2643 DECLARACION(4-4) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-24-0100109 DE FECHA 2024-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-05
|
CHINA
|
0.3 Kgs
|
1 U
|
|
8
|
XXX-03063506
|
DO 25-2643 DECLARACION(3-4) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-24-0100109 DE FECHA 2024-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-05
|
CHINA
|
0.25 Kgs
|
10 U
|
|
9
|
XXX-03063555
|
DO 25-2675 DECLARACION(1-1) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-24-0100109 DE FECHA 2024-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-08-04
|
UNITED STATES
|
3 Kgs
|
39 U
|
|
10
|
XXX-03063512
|
DO 25-2534 DECLARACION(1-2) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-24-0100109 DE FECHA 2024-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-07-23
|
UNITED STATES
|
4 Kgs
|
17 U
|